REGULATORY UPDATE: CBER Announces 2022 Science Symposium

The Center for Biologics Evaluation and Research (CBER) recently released the program agenda for its 2022 Science Symposium, taking place virtually Sept. 20-22.

The symposium will explore topics related to the regulation of biologics and highlight science conducted at CBER by showcasing how scientific research informs regulatory decision-making. It will also provide a forum for developing collaborations within the Food and Drug Administration and with external organizations.

Expert-led presentations at the 2022 Symposium will address advanced manufacturing and analytics; advances in computational science supporting biologics’ evaluation; biomarker discovery: immune responses to vaccination; genome therapy, including gene editing; and emerging and re-emerging diseases.

Registration is open to the public but required to attend.